Afipia clevelandensis

Name:

Afipia clevelandensis Brenner et al. 1992

DSM No.:

7315, Type strain

Strain designation:

411m, B91-007353, F6703, G1849

Other collection no.

or WDCM no.:

ATCC 49720,Cleveland clinic foundation strain

Isolated from:

human tibia, biopsy

Country:

United States of America

Ohio

Date of sampling:

before 04.11.1992

Nagoya Protocol Restrictions:

There are NO known Nagoya Protocol restrictions for this strain.

History:

<- ATCC <- D.J. Brenner; B91-007353 <- G.S. Hall

Cultivation conditions:

Medium 585 , 28°C

Complete DSMZ Media List

Summary and

additional information:

<- ATCC <- D.J. Brenner; B91-007353 <- G.S. Hall. [Cleveland clinic foundation strain]. Human tibia, biopsy; USA, Ohio. Type strain. Taxonomy/description (4535, 4869). Ubiquinone Q-10 (4870). (Medium 585, 28°C)

Literature:

4535, 4869, 4870

Risk group:

2 (classification according to German TRBA)

Restrictions:

Act dealing with the prevention & control of infectious diseases in man (Infektionsschutzgesetz), Category A1

Supplied as:

Delivery form Prices  

Price Category for this culture: 1

Freight and handling charges will be added. See price list.

Note: Freight charges for Risk Group 2 microorganisms will apply.